30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Codexis Inc (CDXS)

Track

In the last 90 days, Codexis Inc. has seen one insider sell shares totaling $6,173.85. This follows a period with multiple sell transactions from various insiders, including the Chief Scientific Officer and President and CEO, with significant aggregate value. The company's stock has experienced a notable price increase of 60.7% over the past 90 days.
Stock chart
Ticker: CDXS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
De Vre Raymond
1 sale — total 100,000 USD
Sale 11 Jun 2026
Value US$3,277,469.70 | Price 251.94 | Shares 51,194
Sale 24 Feb 2026
Value US$828,803.17 | Price 174.41 | Shares 41,245
Proposed sale 24 Feb 2026
Value US$2,013,715.26 | Price 257.43 | Shares 29,447
Sale 6 Feb 2026
Value US$5,000.96 | Price 1.31 | Shares 3,826
Sale 6 Feb 2026
Value US$5,000.96 | Price 1.31 | Shares 3,826
Sale 6 Feb 2026
Value US$3,257.29 | Price 1.31 | Shares 2,492
Proposed sale 6 Feb 2026
Value US$3,124.20 | Price 1.27 | Shares 2,460
Proposed sale 6 Feb 2026
Value US$4,179.57 | Price 1.27 | Shares 3,291
Proposed sale 16 Jan 2026
Value US$2,914.32 | Price 1.67 | Shares 1,745
Sale 7 Jan 2026
Value US$7,949.51 | Price 1.70 | Shares 4,685
Proposed sale 7 Jan 2026
Value US$10,409.10 | Price 1.70 | Shares 6,123
Sale 1 Dec 2025
Value US$14,228.78 | Price 1.67 | Shares 8,533
Sale 1 Dec 2025
Value US$408,537.50 | Price 1.67 | Shares 245,000
Sale 28 Nov 2025
Value US$4,357.50 | Price 1.75 | Shares 2,490
Sale 28 Nov 2025
Value US$183,750.00 | Price 1.75 | Shares 105,000
Sale 26 Nov 2025
Value US$8,706.50 | Price 1.74 | Shares 5,000
Sale 21 Nov 2025
Value US$13,988.40 | Price 1.56 | Shares 8,952
Proposed sale 21 Nov 2025
Value US$13,988.40 | Price 1.56 | Shares 8,952
Sale 12 Nov 2025
Value US$323,730.00 | Price 1.96 | Shares 165,000
Sale 12 Nov 2025
Value US$53,193.57 | Price 1.94 | Shares 27,459
Sale 11 Nov 2025
Value US$2,458.62 | Price 1.74 | Shares 1,413
Sale 11 Nov 2025
Value US$23,771.87 | Price 1.80 | Shares 13,211
Sale 11 Nov 2025
Value US$962,679.00 | Price 1.80 | Shares 535,000
Sale 10 Nov 2025
Value US$5,755.73 | Price 1.73 | Shares 3,318
Sale 10 Nov 2025
Value US$355,613.50 | Price 1.73 | Shares 205,000
Sale 7 Nov 2025
Value US$16,968.00 | Price 1.70 | Shares 10,000
Sale 13 Oct 2025
Value US$15,629.32 | Price 2.51 | Shares 6,239
Proposed sale 13 Oct 2025
Value US$15,629.62 | Price 2.51 | Shares 6,239
Sale 13 Oct 2025
Value US$15,628.70 | Price 2.51 | Shares 6,239
Proposed sale 13 Oct 2025
Value US$15,628.99 | Price 2.51 | Shares 6,239
Buy 4 Aug 2025
Value US$2,211.30 | Price 2.84 | Shares 780
Buy 31 Jul 2025
Value US$225,709.60 | Price 2.68 | Shares 84,220
Buy 30 Jul 2025
Value US$4,410.51 | Price 2.80 | Shares 1,578
Buy 29 Jul 2025
Value US$23,750.04 | Price 2.82 | Shares 8,422
Buy 18 Jul 2025
Value US$282,000.00 | Price 2.82 | Shares 100,000
Buy 27 Jun 2025
Value US$239,000.00 | Price 2.39 | Shares 100,000
Buy 16 Jun 2025
Value US$114,011.52 | Price 2.24 | Shares 50,898
Buy 13 Jun 2025
Value US$220,997.46 | Price 2.23 | Shares 99,102
Buy 12 Jun 2025
Value US$225,000.00 | Price 2.25 | Shares 100,000
Buy 28 May 2025
Value US$11,800.00 | Price 2.36 | Shares 5,000
Buy 23 May 2025
Value US$5,475,200.00 | Price 2.36 | Shares 2,320,000
Buy 1 May 2025
Value US$46,436.00 | Price 2.32 | Shares 20,000
Buy 30 Apr 2025
Value US$57,660.00 | Price 2.31 | Shares 25,000
Buy 25 Apr 2025
Value US$55,915.00 | Price 2.24 | Shares 25,000
Buy 17 Apr 2025
Value US$94,162.50 | Price 2.09 | Shares 45,000
Buy 16 Apr 2025
Value US$148,890.00 | Price 2.13 | Shares 70,000
Buy 15 Apr 2025
Value US$55,720.00 | Price 2.23 | Shares 25,000
Buy 8 Apr 2025
Value US$198,380.00 | Price 1.98 | Shares 100,000
Buy 3 Apr 2025
Value US$172,740.00 | Price 2.30 | Shares 75,000
Buy 2 Apr 2025
Value US$12,276.00 | Price 2.46 | Shares 5,000
Buy 1 Apr 2025
Value US$86,772.00 | Price 2.48 | Shares 35,000
Buy 21 Mar 2025
Value US$236,266.02 | Price 2.54 | Shares 92,923
Buy 20 Mar 2025
Value US$17.97 | Price 2.54 | Shares 7
Buy 13 Mar 2025
Value US$216,155.00 | Price 2.54 | Shares 85,000
Buy 6 Mar 2025
Value US$261,350.00 | Price 2.61 | Shares 100,000
Buy 5 Mar 2025
Value US$26,875.00 | Price 2.69 | Shares 10,000
Buy 4 Mar 2025
Value US$145,398.00 | Price 2.64 | Shares 55,000
Buy 3 Mar 2025
Value US$133,165.22 | Price 2.81 | Shares 47,351
Buy 28 Feb 2025
Value US$441,175.21 | Price 2.99 | Shares 147,649
Buy 12 Feb 2025
Value US$59,932.50 | Price 4.00 | Shares 15,000
Buy 11 Feb 2025
Value US$51,400.00 | Price 4.11 | Shares 12,500
Buy 10 Feb 2025
Value US$94,149.00 | Price 4.18 | Shares 22,500
Buy 31 Jan 2025
Value US$193,185.00 | Price 4.29 | Shares 45,000
Buy 30 Jan 2025
Value US$89,782.00 | Price 4.49 | Shares 20,000
Buy 31 Dec 2024
Value US$46,603.00 | Price 4.66 | Shares 10,000
Buy 30 Dec 2024
Value US$164,391.50 | Price 4.70 | Shares 35,000
Buy 25 Oct 2024
Value US$72,720.00 | Price 2.91 | Shares 25,000
Buy 25 Sep 2024
Value US$14,290.50 | Price 2.86 | Shares 5,000
Buy 24 Sep 2024
Value US$234,856.00 | Price 2.94 | Shares 80,000
Buy 23 Sep 2024
Value US$132,484.50 | Price 2.94 | Shares 45,000
Buy 20 Sep 2024
Value US$135,450.00 | Price 3.01 | Shares 45,000
Buy 20 Sep 2024
Value US$3,040,100.00 | Price 3.01 | Shares 1,010,000
Buy 18 Sep 2024
Value US$18,982.80 | Price 3.16 | Shares 6,000
Buy 18 Sep 2024
Value US$174,009.00 | Price 3.16 | Shares 55,000
Sale 15 Nov 2023
Value US$42,168.00 | Price 2.11 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-11 S Sale
3.0
De Vre Raymond
Non-Executive Director
51,194 -23.2%
251.94
US$3,277,470 		51,194 -23.2% 251.94 US$3,277,470
2026-02-25 2026-02-24 S Sale
1.4
Lutz Stefan

Chief Scientific Officer

Officer
41,245 +8.7%
174.41
US$828,803 		41,245 +8.7% 174.41 US$828,803
2026-02-23 2026-02-24 PrS Proposed sale
1.4
Lutz Stefan

Officer

Officer
29,447
257.43
US$2,013,715 		29,447 257.43 US$2,013,715
2026-02-09 2026-02-06 S Sale
3.9
Erbez Georgia

See Remarks

Officer
3,826 -5.4%
1.31
US$5,001 		3,826 -5.4% 1.31 US$5,001
2026-02-09 2026-02-06 S Sale
3.0
MOORE ALISON

President and CEO

Executive Director
3,826 -1.5%
1.31
US$5,001 		3,826 -1.5% 1.31 US$5,001
2026-02-09 2026-02-06 S Sale
1.4
Lutz Stefan

Chief Scientific Officer

Officer
2,492 -1.8%
1.31
US$3,257 		2,492 -1.8% 1.31 US$3,257
2026-02-06 2026-02-06 PrS Proposed sale
3.9
Norrett Kevin

Officer; Former Chief Operating Officer

Officer
3,291
1.27
US$4,180 		3,291 1.27 US$4,180
2026-02-06 2026-02-06 PrS Proposed sale
1.4
Lutz Stefan

Officer

Officer
2,460
1.27
US$3,124 		2,460 1.27 US$3,124
2026-01-16 2026-01-16 PrS Proposed sale
3.9
KEVIN NORRETT

Officer

Officer
1,745
1.67
US$2,914 		1,745 1.67 US$2,914
2026-01-08 2026-01-07 S Sale
1.4
Lutz Stefan

CSO

Officer
4,685 -3.3%
1.70
US$7,950 		4,685 -3.3% 1.70 US$7,950
2026-01-07 2026-01-07 PrS Proposed sale
3.9
Norrett Kevin

Officer

Officer
6,123
1.70
US$10,409 		6,123 1.70 US$10,409
2025-12-01 2025-12-01 S Sale
3.3
Opaleye Management Inc.
Large shareholder
8,533 -4.5%
1.67
US$14,229 		8,533 -4.5% 1.67 US$14,229
2025-12-01 2025-12-01 S Sale
3.3
Opaleye Management Inc.
Large shareholder
245,000 -2.4%
1.67
US$408,538 		245,000 -2.4% 1.67 US$408,538
2025-12-01 2025-11-28 S Sale
3.3
Opaleye Management Inc.
Large shareholder
2,490 -1.3%
1.75
US$4,358 		2,490 -1.3% 1.75 US$4,358
2025-12-01 2025-11-28 S Sale
3.3
Opaleye Management Inc.
Large shareholder
105,000 -1.0%
1.75
US$183,750 		105,000 -1.0% 1.75 US$183,750
2025-12-01 2025-11-26 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,000 -2.6%
1.74
US$8,706 		5,000 -2.6% 1.74 US$8,706
2025-11-25 2025-11-21 S Sale
1.7
WOLF DENNIS P
Non-Executive Director
8,952 -6.1%
1.56
US$13,988 		8,952 -6.1% 1.56 US$13,988
2025-11-21 2025-11-21 PrS Proposed sale
1.7
DENNIS P WOLF

Officer

Officer
8,952
1.56
US$13,988 		8,952 1.56 US$13,988
2025-11-14 2025-11-12 S Sale
3.3
Opaleye Management Inc.
Large shareholder
165,000 -1.6%
1.96
US$323,730 		165,000 -1.6% 1.96 US$323,730
2025-11-14 2025-11-12 S Sale
3.3
Opaleye Management Inc.
Large shareholder
27,459 -12.3%
1.94
US$53,194 		27,459 -12.3% 1.94 US$53,194
2025-11-13 2025-11-11 S Sale
3.0
De Vre Raymond
Non-Executive Director
1,413 -1.6%
1.74
US$2,459 		1,413 -1.6% 1.74 US$2,459
2025-11-12 2025-11-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
13,211 -5.6%
1.80
US$23,772 		13,211 -5.6% 1.80 US$23,772
2025-11-12 2025-11-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
535,000 -4.4%
1.80
US$962,679 		535,000 -4.4% 1.80 US$962,679
2025-11-12 2025-11-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
3,318 -1.4%
1.73
US$5,756 		3,318 -1.4% 1.73 US$5,756
2025-11-12 2025-11-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
205,000 -1.7%
1.73
US$355,614 		205,000 -1.7% 1.73 US$355,614
2025-11-12 2025-11-07 S Sale
3.3
Opaleye Management Inc.
Large shareholder
10,000 -4.0%
1.70
US$16,968 		10,000 -4.0% 1.70 US$16,968
2025-10-15 2025-10-13 S Sale
3.0
MOORE ALISON

Chief Technical Officer

Officer
6,239 -3.6%
2.51
US$15,629 		6,239 -3.6% 2.51 US$15,629
2025-10-15 2025-10-13 S Sale
3.9
Erbez Georgia

Chief Financial Officer

Officer
6,239 -8.1%
2.51
US$15,629 		6,239 -8.1% 2.51 US$15,629
2025-10-14 2025-10-13 PrS Proposed sale
3.0
MOORE ALISON

Officer

Officer
6,239
2.51
US$15,630 		6,239 2.51 US$15,630
2025-10-14 2025-10-13 PrS Proposed sale
3.9
Erbez Georgia

Officer

Officer
6,239
2.51
US$15,629 		6,239 2.51 US$15,629
2025-08-04 2025-08-04 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
780 +0.0%
2.84
US$2,211 		780 +0.0% 2.84 US$2,211
2025-08-04 2025-07-31 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
84,220 +0.7%
2.68
US$225,710 		84,220 +0.7% 2.68 US$225,710
2025-07-31 2025-07-30 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,578 +0.0%
2.80
US$4,411 		1,578 +0.0% 2.80 US$4,411
2025-07-31 2025-07-29 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
8,422 +0.1%
2.82
US$23,750 		8,422 +0.1% 2.82 US$23,750
2025-07-22 2025-07-18 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
100,000 +0.8%
2.82
US$282,000 		100,000 +0.8% 2.82 US$282,000
2025-07-01 2025-06-27 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
100,000 +0.8%
2.39
US$239,000 		100,000 +0.8% 2.39 US$239,000
2025-06-16 2025-06-16 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
50,898 +0.4%
2.24
US$114,012 		50,898 +0.4% 2.24 US$114,012
2025-06-16 2025-06-13 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
99,102 +0.8%
2.23
US$220,997 		99,102 +0.8% 2.23 US$220,997
2025-06-16 2025-06-12 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
100,000 +0.8%
2.25
US$225,000 		100,000 +0.8% 2.25 US$225,000
2025-05-28 2025-05-28 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
5,000 +0.0%
2.36
US$11,800 		5,000 +0.0% 2.36 US$11,800
2025-05-28 2025-05-23 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
2,320,000 +24.0%
2.36
US$5,475,200 		2,320,000 +24.0% 2.36 US$5,475,200
2025-05-02 2025-05-01 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
20,000 +0.2%
2.32
US$46,436 		20,000 +0.2% 2.32 US$46,436
2025-05-02 2025-04-30 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
25,000 +0.3%
2.31
US$57,660 		25,000 +0.3% 2.31 US$57,660
2025-04-29 2025-04-25 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
25,000 +0.3%
2.24
US$55,915 		25,000 +0.3% 2.24 US$55,915
2025-04-17 2025-04-17 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
45,000 +0.5%
2.09
US$94,162 		45,000 +0.5% 2.09 US$94,162
2025-04-17 2025-04-16 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
70,000 +0.7%
2.13
US$148,890 		70,000 +0.7% 2.13 US$148,890
2025-04-17 2025-04-15 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
25,000 +0.3%
2.23
US$55,720 		25,000 +0.3% 2.23 US$55,720
2025-04-09 2025-04-08 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
100,000 +1.1%
1.98
US$198,380 		100,000 +1.1% 1.98 US$198,380
2025-04-03 2025-04-03 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
75,000 +0.8%
2.30
US$172,740 		75,000 +0.8% 2.30 US$172,740
2025-04-03 2025-04-02 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
5,000 +0.1%
2.46
US$12,276 		5,000 +0.1% 2.46 US$12,276
2025-04-03 2025-04-01 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
35,000 +0.4%
2.48
US$86,772 		35,000 +0.4% 2.48 US$86,772
2025-03-24 2025-03-21 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
92,923 +1.0%
2.54
US$236,266 		92,923 +1.0% 2.54 US$236,266
2025-03-24 2025-03-20 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
7 +0.0%
2.54
US$18 		7 +0.0% 2.54 US$18
2025-03-14 2025-03-13 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
85,000 +0.9%
2.54
US$216,155 		85,000 +0.9% 2.54 US$216,155
2025-03-10 2025-03-06 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
100,000 +1.1%
2.61
US$261,350 		100,000 +1.1% 2.61 US$261,350
2025-03-06 2025-03-05 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
10,000 +0.1%
2.69
US$26,875 		10,000 +0.1% 2.69 US$26,875
2025-03-06 2025-03-04 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
55,000 +0.6%
2.64
US$145,398 		55,000 +0.6% 2.64 US$145,398
2025-03-04 2025-03-03 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
47,351 +0.5%
2.81
US$133,165 		47,351 +0.5% 2.81 US$133,165
2025-03-04 2025-02-28 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
147,649 +1.7%
2.99
US$441,175 		147,649 +1.7% 2.99 US$441,175
2025-02-12 2025-02-12 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
15,000 +0.2%
4.00
US$59,932 		15,000 +0.2% 4.00 US$59,932
2025-02-12 2025-02-11 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
12,500 +0.1%
4.11
US$51,400 		12,500 +0.1% 4.11 US$51,400
2025-02-12 2025-02-10 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
22,500 +0.3%
4.18
US$94,149 		22,500 +0.3% 4.18 US$94,149
2025-01-31 2025-01-31 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
45,000 +0.5%
4.29
US$193,185 		45,000 +0.5% 4.29 US$193,185
2025-01-31 2025-01-30 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
20,000 +0.2%
4.49
US$89,782 		20,000 +0.2% 4.49 US$89,782
2025-01-02 2024-12-31 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
10,000 +0.1%
4.66
US$46,603 		10,000 +0.1% 4.66 US$46,603
2025-01-02 2024-12-30 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
35,000 +0.4%
4.70
US$164,392 		35,000 +0.4% 4.70 US$164,392
2024-10-28 2024-10-25 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
25,000 +0.3%
2.91
US$72,720 		25,000 +0.3% 2.91 US$72,720
2024-09-26 2024-09-25 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
5,000 +0.1%
2.86
US$14,290 		5,000 +0.1% 2.86 US$14,290
2024-09-26 2024-09-24 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
80,000 +0.9%
2.94
US$234,856 		80,000 +0.9% 2.94 US$234,856
2024-09-23 2024-09-23 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
45,000 +0.5%
2.94
US$132,484 		45,000 +0.5% 2.94 US$132,484
2024-09-23 2024-09-20 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
45,000 +22.0%
3.01
US$135,450 		45,000 +22.0% 3.01 US$135,450
2024-09-23 2024-09-20 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,010,000 +13.7%
3.01
US$3,040,100 		1,010,000 +13.7% 3.01 US$3,040,100
2024-09-19 2024-09-18 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
6,000 +3.0%
3.16
US$18,983 		6,000 +3.0% 3.16 US$18,983
2024-09-19 2024-09-18 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
55,000 +0.8%
3.16
US$174,009 		55,000 +0.8% 3.16 US$174,009
2023-11-17 2023-11-15 S Sale
0.5
Dorgan Byron L
Non-Executive Director
20,000 -9.4%
2.11
US$42,168 		20,000 -9.4% 2.11 US$42,168
Explore more

More insider trading research around Codexis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America